Our Initiatives

Quickly consult our archives filtering by year :

Swiss HLG and BaselArea are excited to invite you to the Swiss HLG’s 4th start-up workshop collaboration.

“Valuation of Early Stage Biotech Companies – Net Present Value versus VC approach.”

The risk-adjusted, net present value (rNPV) method is the standard valuation method used within pharma and biotech companies when valuing assets beyond discovery stage. This approach depicts the drug/pipeline development plan using R&D costs & timeline, success rates, and peak sales potential. The quantity of available information in the pharmaceutical area enables to determine and benchmark those assumptions. Well-calibrated the rNPV method is thus a powerful tool to build, challenge and value the company’s strategy. It also shows how the value of the company develops along reaching milestones. Is it however enough for investors?

From an investor’s perspective, it is crucial to understand how long it takes before an exit and what is the potential for ROI (Return on Investment). They need to figure out the conditions to harvest their investment as well as to anticipate the multiple later-round investors and incentive packages to key employees that may dilute their stake.

While rNPV highlights the roadmap for the scientific bet of the company, the VC method highlights the one for the cash to be invested in.

The purpose of this workshop is to decrypt the reasons behind using rNPV or VC methodologies to value a Biotech company. With the support of interactive cases, the participants will learn more about how Biotech companies can better anticipate the VCs’ point of view when presenting their valuation work.

Workshop Details:
Thursday, 8th February 2018
16:00
24 Gewerbestrasse, Swiss Innovation Parc-Allschwil

Participation is free of charge, but seats are limited.

To register,  email: stephan.emmerth@baselarea.swiss , please mention when registering that you are a  Swiss HLG member.

Registration is compulsory and subjected to validation. Priority is given to people with founded start-ups or concrete projects.

We look forward to meeting you there.

 

“Ensuring Smooth Tech Transfer between Start-ups and Universities”

Start-up initiative - Swiss HLG

 

Swiss HLG in collaboration with BaselArea presented a special seminar for the 13th Start-up BaseLaunch initiative in October 2017.

Alexandra Carrel, a Swiss HLG member, presented an informative session on “How Start-ups should deal with Tech Transfer Offices.” The attendees benefitted by receiving practical tips and advice on Licensing issues in this specific and usually challenging context.The workshop explained the viewpoints from both Start-ups and Universities and gave clear strategies on how to proceed to achieve a successful negotiation.

If you are interested in further information regarding the Start-up initiative, please contact our Board Member, Zaki Sellam – zaki.sellam@swisshlg.com 

The Swiss HLG is committed to supporting and developing the Healthcare Start-up scene. As one of our new initiatives, we have developed a unique membership package, tailored specifically to meet their needs.

If you know a startup that could benefit from becoming a member of the Swiss HLG, please share our latest offer with them and help make our association network even better!

This offer is valid until December 2018.

 

“Ensuring Smooth Tech Transfer between Start-ups and Universities”

October 5th, 2017

Start-up initiative - Swiss HLG

As part of the Swiss HLG Start-up initiative to support local entrepreneurs, we will work in collaboration with BaselArea Swiss, to present our latest Start-up Workshop. Most Start-ups are leveraging assets that are coming from universities. Executing this transfer smoothly is not always easy.

Both types of organizations have different missions and agendas, which sometimes results in conflicting interests and hectic negotiations. This workshop will explain the viewpoint from both parties and give clear strategies for a successful negotiation.

Registration and venue details will be released shortly.

For any queries, please contact our Board Member responsible for this initiative, Zaki Sellam – zaki.sellam@swisshlg.com

Join us, become a member !

Join Swiss HLG
as a member

Newsletter

Keep up to date with the latest information by signing up to our newsletter

Why it's worth joining us !

Learn more about Swiss HLG
and our initiatives